Clinical Trial Update: Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial [Phase 2]

View source ↗

Summary

This clinical trial update discusses the START trial, a Phase 2 study assessing sequential two-agent therapy for renal cell carcinoma. The study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING